Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01793493
Other study ID # 02
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date March 2011
Est. completion date June 2015

Study information

Verified date September 2023
Source Fondazione Golgi Cenci
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The Allena-Mente study is a randomized, controlled, single-blind trial assessing the efficacy of cognitive stimulation (CS) compared to an active control group, participating to sanitary education lessons (AC). This non-pharmacological intervention is delivered to Mild Cognitive Impairment (MCI) and cognitively healthy individuals with first-degree relative with dementia (NDFAM).


Description:

The experimental protocol was set up with a pilot study on healthy elderly individuals. Data from this pilot study will be excluded from the statistical analysis. Sample size: a priori power analysis was performed to evaluate the sample size required for the study. MCI and NDFAM were considered separately for sample size calculation. For power calculation a two-tailed test was used and a significance level (α) and test power (1-β) were set at 0.05 and 0.8/0.9, respectively. Randomization: The individuals belonging to MCI and NDFAM subgroup were randomly assigned to CS or AC group. The randomization was performed by a statistician blind to participants characteristics using the Random Allocation Software. Allocation ratio was set at 1:1, stratification was performed for birth cohort (≤1937 and ≥1938), education level (years of education ≤5 years and >5 years). Participants provided written informed consent before study participation.


Recruitment information / eligibility

Status Completed
Enrollment 121
Est. completion date June 2015
Est. primary completion date March 2015
Accepts healthy volunteers No
Gender All
Age group 70 Years to 75 Years
Eligibility Inclusion Criteria: - Positive diagnosis for mild cognitive impairment (MCI) according to Petersen's criteria; - Cognitively healthy elderly individuals, having at least one first-degree relative affected by dementia (Alzheimer's Disease, pre-senile and senile dementia, vascular dementia) (NDFAM). Exclusion Criteria: - (Major physical illness) Compromission of motor performance of lower and upper limbs - Medical conditions leading to clinical instability; - Therapies that reduce cognitive and communicative abilities and consciousness; - Perceptual disorders (sight, hearing) - Language disorders - Education level lower than 3 years - Psychiatric and behavioral disorders - Addiction to drugs or alcohol

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Cognitive stimulation
Participants are pooled in small groups (6-8 individuals). Each group participates to ten twice weekly meetings. Each CS session is run by one trained operator. One observer participates to the sessions to guarantee homogeneity between different operators. Exercises are structured with an increasing cognitive complexity and are tailored to the characteristics of the group. Meetings (each lasting about 2 hours) have a common structure: body awakening (10 minutes) cognitive stimulation (1 hour and a half) scheduled as follow: temporospatial orientation attentional abilities one of the following cognitive areas: language, executive functions, verbal and visual memory (encoding, consolidation, retrieval)
Sanitary education
Participants attend two weekly meetings (for a total of 3 hours) focused on lifestyle education and brain functioning.

Locations

Country Name City State
Italy Golgi Cenci Foundation Abbiategrasso Milan

Sponsors (5)

Lead Sponsor Collaborator
Fondazione Golgi Cenci Alzheimer Federation Italy, Camillo Golgi Geriatric Institute, Mario Negri Institute for Pharmacological Research, University of Pavia

Country where clinical trial is conducted

Italy, 

References & Publications (1)

Polito L, Abbondanza S, Vaccaro R, Valle E, Davin A, Degrate A, Villani S, Guaita A. Cognitive stimulation in cognitively impaired individuals and cognitively healthy individuals with a family history of dementia: short-term results from the "Allena-Mente" randomized controlled trial. Int J Geriatr Psychiatry. 2015 Jun;30(6):631-8. doi: 10.1002/gps.4194. Epub 2014 Sep 3. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Long-term change from Baseline in Mini Mental State Examination (MMSE) Mini Mental State examination (MMSE) is a brief test of mental status and cognitive function, commonly used in clinical research to screen global cognitive functioning. baseline and up to 4 years
Secondary Change from Baseline in Mini Mental State Examination at 2-weeks after the intervention MMSE is a brief test of mental status and cognitive function, commonly used in clinical research to screen global cognitive functioning. baseline, two-weeks after the intervention
Secondary Change from Baseline in Montreal Cognitive Assessment (MoCA) at 2-weeks after the intervention MoCA is a brief cognitive screening tool with a high sensitivity and specificity for detecting MCI in individuals performing in the normal range on the MMSE (avoiding ceiling effect). baseline, two-weeks after the intervention
Secondary Change from Baseline in Corsi test at 2-weeks after the intervention Corsi test evaluates visual-spatial short-term memory. We used this test to implement non-verbal memory in our neuropsychological test battery baseline, two-weeks after the intervention
Secondary Change from Baseline in Walking While Talking Dual Task at 2-weeks after the intervention Walking speed measures the ability to perform a dual action task. Single task: participants walk back and forth along an indicated distance of 5 meters with no pausing.
Dual task: participants perform the same movement as in the single task while listing personal names in a loud voice (female names for men and male names for women) The span between time needed to perform the dual and the single task is registered.
baseline, two-weeks after the intervention
See also
  Status Clinical Trial Phase
Completed NCT04513106 - Promoting Advance Care Planning for Persons With Early-stage Dementia in the Community: a Feasibility Trial N/A
Recruiting NCT06011681 - The Rapid Diagnosis of MCI and Depression in Patients Ages 60 and Over
Recruiting NCT04522739 - Spironolactone Safety in African Americans With Mild Cognitive Impairment and Early Alzheimer's Disease Phase 4
Active, not recruiting NCT03167840 - Falls Prevention Through Physical And Cognitive Training in Mild Cognitive Impairment N/A
Active, not recruiting NCT03676881 - Longitudinal Validation of a Computerized Cognitive Battery (Cognigram) in the Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease
Not yet recruiting NCT05041790 - A Clinical Trial to Evaluate the Efficacy and Safety of Choline Alfoscerate Compared to Placebo in Patients With Degenerative Mild Cognitive Impairment Phase 4
Recruiting NCT04121156 - High Definition Transcranial Direct Current Stimulation (HD-tDCS) in Patients With Mild Cognitive Impairment N/A
Recruiting NCT03605381 - MORbidity PRevalence Estimate In StrokE
Completed NCT02774083 - Cognitive Training Using Feuerstein Instrumental Enrichment N/A
Completed NCT01315639 - New Biomarker for Alzheimer's Disease Diagnostic N/A
Enrolling by invitation NCT06023446 - Can (Optical Coherence Tomography) Pictures of the Retina Detect Alzheimer's Disease at Its Earliest Stages?
Completed NCT04567745 - Automated Retinal Image Analysis System (EyeQuant) for Computation of Vascular Biomarkers Phase 1
Recruiting NCT05579236 - Cortical Disarray Measurement in Mild Cognitive Impairment and Alzheimer's Disease
Completed NCT03583879 - Using Gait Robotics to Improve Symptoms of Parkinson's Disease N/A
Terminated NCT02503501 - Intranasal Glulisine in Amnestic Mild Cognitive Impairment and Probable Mild Alzheimer's Disease Phase 2
Not yet recruiting NCT03740178 - Multiple Dose Trial of MK-4334 in Participants With Alzheimer's Clinical Syndrome (MK-4334-005) Phase 1
Active, not recruiting NCT05204940 - Longitudinal Observational Biomarker Study
Recruiting NCT02663531 - Retinal Neuro-vascular Coupling in Patients With Neurodegenerative Disease N/A
Recruiting NCT06150352 - Sleep Apnea, Neurocognitive Decline and Brain Imaging in Patients With Subjective or Mild Cognitive Impairment
Recruiting NCT03507192 - Effects of Muscle Relaxation on Cognitive Function in Patients With Mild Cognitive Impairment and Early Stage Dementia. N/A